150 Logo 4357 (Ranitidine 150 mg)

Pill imprint 150 Logo 4357 has been identified as Ranitidine hydrochloride 150 mg.

Ranitidine is used in the treatment of gerd; erosive esophagitis; gastric ulcer maintenance treatment; zollinger-ellison syndrome; duodenal ulcer (and more), and belongs to the drug class H2 antagonists. There is no proven risk in humans during pregnancy. Ranitidine 150 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for 150 Logo 4357

Ranitidine hydrochloride 150 mg 150 Logo 4357
Ranitidine hydrochloride 150 mg 150 Logo 4357
Ranitidine hydrochloride 150 mg 150 Logo 4357
Ranitidine hydrochloride
Imprint:
150
Logo 4357
Strength:
150 mg
Color:
Beige
Size:
9.00 mm
Shape:
Round
Availability:
Rx and/or OTC
Drug Class:
H2 antagonists
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Teva Pharmaceuticals USA
National Drug Code (NDC):
00172-4357
Inactive Ingredients:
croscarmellose sodium
hypromelloses
lactose monohydrate
magnesium stearate
microcrystalline cellulose
ferric oxide red
titanium dioxide
triethyl citrate
ferric oxide yellow

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web4)